Latest filing published 13 Jul 2026 for UNITED THERAPEUTICS Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Louis W. Sullivan span 2 companies, the busiest being UNITED THERAPEUTICS Corp and Emergent BioSolutions Inc. Over a trading history stretching from 10 May 2021 to 9 July 2026, the count stands at 24 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 13 July 2026 came the latest disclosure, an option exercise in UNITED THERAPEUTICS Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations